Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 36 Results

Intervention Indication Therapeutic Area Year Actions
BI 1015550 for treating idiopathic pulmonary fibrosis or progressive pulmonary fibrosis BI 1015550 Idiopathic pulmonary fibrosis , Progressive pulmonary fibrosis Respiratory System 2024 View  |  Download
Blinatumomab with chemotherapy for frontline consolidation treatment of Philadelphia chromosome negative, measurable residual disease negative, B-lineage acute lymphoblastic leukaemia Blinatumomab (Blincyto) , Chemotherapy Acute lymphoblastic leukaemia (ALL) Haematological Cancer and Lymphomas 2024 View  |  Download
Brensocatib for people aged 12 and over with non-cystic fibrosis bronchiectasis Brensocatib (AZD-7986) Bronchiectasis Respiratory System 2024 View  |  Download
Brentuximab vedotin with chemotherapy (BrECADD) for previously untreated advanced classical Hodgkin lymphoma Brentuximab vedotin (Adcetris; SGN-35) , Chemotherapy Hodgkin lymphoma Haematological Cancer and Lymphomas 2024 View  |  Download
Brentuximab vedotin with cyclophosphamide, prednisone and doxorubicin for treating peripheral Tcell lymphoma Brentuximab vedotin (Adcetris; SGN-35) , Cyclophosphamide (Procytox; cyclophosphamide monohydrate) , Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Prednisone (Decadron; Lodotra) Peripheral T-cell lymphoma (PTCL) Haematological Cancer and Lymphomas 2024 View  |  Download
Budesonide-glycopyrronium-formoterol fumarate for the treatment of severe and inadequately controlled asthma Budesonide-glycopyrronium-formoterol fumarate Asthma Respiratory System 2024 View  |  Download
Datopotamab deruxtecan for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer Datopotamab deruxtecan (DS-1062) Breast cancer Breast Cancer 2024 View  |  Download
Depemokimab as adjunctive therapy for severe asthma with an eosinophilic phenotype in patients aged 12 years and older Depemokimab Asthma Respiratory System 2024 View  |  Download
Depemokimab for treating chronic rhinosinusitis withnasal polyps Depemokimab Nasal polyps , Rhinosinusitis Ear Nose and Throat (ENT) 2024 View  |  Download
DMX-200 for treating focal segmental glomerulosclerosis in people receiving angiotensin II receptor blocker therapy DMX-200 Focal segmental glomerulosclerosis (FSGS) Nephrology 2024 View  |  Download
1 2 3 4
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications